Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (SPACE)

被引：8
|
作者：
Lencioni, R.
Zou, J.
Leberre, M.
Meinhardt, G.
Voliotis, D.
Bruix, J.
Llovet, J. M.
机构：
[1] Cisanello Univ Hosp, Pisa, Italy
[2] Bayer HealthCare Pharmaceut, Shanghai, Peoples R China
[3] Bayer Sante, Div Bayer Schering Pharma, Loos, France
[4] Bayer HealthCare Pharmaceut, Montville, NJ USA
[5] Hosp Clin Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, CIBERend,IDIBAPS, Barcelona, Spain
[6] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS178
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
    Lu, Linbin
    Zheng, Peichan
    Wu, Zhixian
    Chen, Xiong
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
    Izumoto, Hirofumi
    Hiraoka, Atsushi
    Ishimaru, Yoshihiro
    Murakami, Tadashi
    Kitahata, Shogo
    Ueki, Hidetaro
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Miyamoto, Yuji
    Yamago, Hiroka
    Iwasaki, Ryuichiro
    Tomida, Hideomi
    Mori, Kenichiro
    Kishida, Masato
    Tsubouchi, Eiji
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Kawasaki, Hideki
    Hirooka, Masashi
    Matsuura, Bunzo
    Abe, Masanori
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    [J]. ONCOLOGY, 2017, 93 : 120 - 126
  • [23] OVERALL SURVIVAL IN INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS AFTER FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE): PROPOSAL OF A NEW SCORING SYSTEM
    Sacco, R.
    Ginanni, B.
    Mismas, V.
    Masi, G.
    De Simone, P.
    Romano, A.
    Bresci, G.
    Bartolozzi, C.
    Bargellini, I.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E44 - E44
  • [24] Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients
    Caihua Zhu
    Bing Dai
    Hua Zhan
    Ruoyu Deng
    [J]. Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1065 - 1071
  • [25] Transarterial Chemoembolization (TACE) Combined With Sorafenib versus TACE in Patients With BCLC Stage C Hepatocellular Carcinoma - A Retrospective Study
    Patidar, Yashwant
    Chandel, Karamvir
    Condati, Naveen K.
    V. Srinivasan, Shyam
    Mukund, Amar
    Sarin, Shiv K.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (03) : 745 - 754
  • [26] LEAP-012 trial in progress: Transarterial chemoembolization (TACE) with or without lenvatinib plus pembrolizumab for intermediate-stage hepatocellular carcinoma (HCC)
    El-Khoueiry, Anthony B.
    Llovet, Josep M.
    Vogel, Arndt
    Madoff, David C.
    Finn, Richard S.
    Ogasawara, Sadahisa
    Ren, Zhenggang
    Mody, Kalgi
    Li, Jerry J.
    Siegel, Abby B.
    Dubrovsky, Leonid
    Kudo, Masatoshi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [27] Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma
    Hung, Ya-Wen
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chiu, Nai-Chi
    Hwang, Hsuen-En
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. LIVER CANCER, 2024, 13 (01) : 29 - 40
  • [28] Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy
    Hatanaka, Takeshi
    Yata, Yutaka
    Naganuma, Atsushi
    Kakizaki, Satoru
    [J]. CANCERS, 2023, 15 (06)
  • [29] Post progression survival in patients with intermediate-stage hepatocellular carcinoma after receiving transarterial chemoembolization
    Shima, Yukiko
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kobayashi, Kazufumi
    Maruta, Susumu
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maeda, Takahiro
    Kusakabe, Yuko
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E75 - E75
  • [30] Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients
    Zhu, Caihua
    Dai, Bing
    Zhan, Hua
    Deng, Ruoyu
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1065 - 1071
12345